Post by ProQR Therapeutics
18,164 followers
Drug discovery can be slow and patients are waiting. We have partnered with Ginkgo Bioworks to advance our #Axiomer #RNAEditing platform, leveraging their autonomous lab for high throughput data generation to power our AI-driven drug discovery. Our CEO Daniel de Boer and Ginkgo CEO Jason Kelly sat together to discuss how our collaboration is accelerating timelines. #Biotech #AI
Video Content